Kendalle Burlin O'Connell, Esq.’s Post

Important work here by the MassBio team led by Kendalle Burlin O'Connell, Esq. on behalf of all MA based life science focused companies The stats support continued investment at the scale proposed… We now have 2x the number of life science employees in the state since the first MA life science investment initiative was authorized in 2008 Which meant $22Bn in wages in 2023 (great for MA revenues) And this base of talent is helping to attract major investment into new promising technologies that will shape the future of medicine and the health of the nation…that’s 30%+ of all biotech VC dollars the last few years (>$7 Bn per year since 2020…and $13.66 Bn in 2021) #biotech #research #medicine #healthcare Nicholas Collins

People don't know how bad the current situation is and that it is likely to get worse-especially for small founder driven biotechs. (previously the Paw Sox but now the Woo Sox of biotech--very appropriately collocated). You can look at recent Carta statistics for how small startups are faring... In biotech, founders might be diluted out 50 percent or more even at the smallest seed or series A stage. They are doing it because of a dream, but you can help them get there. And maybe one of them will have the next Alzheimer's or Als or Parkinson's drug. They individually will probably get nothing financially, but maybe they will get to try again and do more next time. And if it succeeds it's a wonderful thing for humanity. We are entering one of the most exciting times in biotech... the truth is that most biotech founders will get diluted out unless they stay in the c suite until the end--this is a very expensive industry--but if the drug succeeds it is a win for humanity.. People see the biotech and pharma as very profit driven--but what is the profit margin on you phone? These therapeutics are so essential that to be denied them makes the companies involved the bad guys... If we look at Biocytogen for instance--a Worcester success story--we can ask would that happen today now that various foreign investment sources are cut off? In a way that is what CFIUS does -- which is fine -- but what does it provide in return... Some companies would not survive or even start without foreign investment.... (and this might include companies with American founders that might look a little bit less typical). Who do Arpa-H grants go to? Often they go to those with an established track record not the explorers searching for the most optimal business opportunity. Afeyan calls these the intellectual immigrants but they might be hard for grants committees to assess. Possibly investors are more sophisticated at it (and this also includes international investors) -- which the US seems to want to send to Europe(?) Great science is being done here. You can help provide the small startups a foothold, or you can focus on other things... but biology is the most promising technology of our time--that is why you see the capital inflows to the larger players. Sometimes science surprises--just today there was a fantastic breakthrough from San Antonio in immune system models. Is it a surprise that it is happening in Texas which is supporting startups? Some of these small ones might succeed if you help provide fertile ground for it. If so, humanity will be the primary beneficiary. And scientists and founders get a start in a great community where there are both the professional and non-professional biotech leagues.... It's all part if the game. Paw Sox and Red Sox but both can have great players. And if science advances enough, maybe both can win. For now you get to decide what to do with the Paw Sox. Should they stay here or go to Texas and California?

"Last week the Labour Party launched its Life Sciences Plan which has been warmly welcomed across the board by industry, with positive responses from ABPI, Life Arc and others. With a focus on implementation over revolution of the existing Life Sciences Vision, Labour appear to be sending the message that they understand that the sector wants certainty and practicalities over new grand strategies.  "Lots will be written over the soundness of this as political strategy and what it means for polling day, though I doubt the next election will be won or lost on life sciences sector policies. However, regardless of the colour of the next government, elements of this plan are likely to be adopted into mainstream policy and it’s interesting to dissect them and what they mean for the North. Bear in mind that at this stage we’ve only seen the outline plan of actions and no detail.  "I’m going to start with what’s not in it – MedTech." Read our full blog from Ben Martyn on Labour's Life Sciences Plan and how the proposed actions could mean for the North of England.

#dll providing innovative funding solutions to a key UK market sector in #lifesciences #Euipmentfunding #Laboratory #Lifesciences #Scientist #Research #DLL #cfo #cro #cdmo #biotech #bigpharma #pharmaceutical #pharma #laboratoryequipment

Get to know our amazing Assistant Director for our Science and Medicine team, Gemma Payne. Who else was amazed by Gemma's fact? Comment your favourite science fact, we would love to know! #ScienceWeek #ProtectingSportTogether #NationalScienceWeek

#ResearchWithinReach Research Deserts exist across the midwest, especially in Illinois. Unless you live next to a giant city, your community often does not have the specialized doctors, the infrastructure, or the experienced professionals to be a part of clinical research. And so - you commute 3-9 hours one way to access the clinical trials that you need to live a happy life. Why?! This isn't sustainable for the average rural American..... How will you work, be with family, or have a life all while fighting a challenging diagnosis AND becoming a trial participant commuter? You don't have to........ Land of Lincoln Clinical Research is bring the trial to you.... right to your doctor's office. The doctor you know, choose, and trust. The doctor who knows your story. All without your doctor having to be a full time researcher. And all for your complete convenience. Talk to your doctor - seriously - about participating in clinical research. And ask them to contact LoLCR today to learn how we may bring a world of trial opportunities they never knew existed. Like/Follow/Share the LoLCR story. And learn how we can truly achieve #ResearchWithinReach..... in Central Illinois. #lolcr

This is so interesting. Linking with perimenopause. #meg #perimenopausehealth #perimenopause https://lnkd.in/esbfnB4J

What if you went to get up one day and you couldn’t? People suffering from pots miss out on some much of life and then become the missing. Do you or someone you know have POTS? ✅👍This conference is not to be missed. There is a day dedicated JUST FOR YOU!!! I am heading down and most excited to get the latest information and research. To understand more about the condition and how to live with it on a daily basis. Come join us, time is running out. #POTS #livingwithpots

📰 NEW BLOG: ORAU provides innovative scientific and technical solutions for the U.S. Department of Energy and other federal agencies to advance national priorities in science, health and education. Click the link below to learn about the core values that define ORAU and the ways we support our customers 🔽 🔽 🔽 https://bit.ly/3VkOMJM #FurtherTogether

Acceptance of scientific research about ACL INJURY AND rehabilitation For presentation at the International Conference On Recent Advances In Medical And Health Sciences (ICRAMHS - 24) taking place on 2nd Sep - 3rd Sep'2024